| Name | Title | Contact Details |
|---|
Premier Healthcare Professionals is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Hematology-Oncology Associates of Central New York is a East Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salon 01 is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The new Actavis, Inc. (NYSE:ACT) is a combination of the previously separate Watson Pharmaceuticals, Inc. and Swiss-based Actavis Group. Actavis, Inc. is a specialty pharmaceutical company that develops, manufactures and distributes generic, brand and biosimilar products. The Company has global headquarters in Parsippany, NJ and international headquarters in Zug, Switzerland.